Literature DB >> 16012031

Telomerase activity and cell proliferation index in cholesteatoma.

Seung Hwan Lee1, Young Ho Jang, Kyung Tae, Yong Wook Park, Mi Jung Kang, Kyung Rae Kim, Chul Won Park.   

Abstract

CONCLUSIONS: Telomerase activity was expressed in cholesteatomas, and cellular proliferation was significantly higher in cases where the telomerase activity was positive. Telomerase activity was also closely related with cellular proliferation in chronic hyperproliferating tissues such as cholesteatomas.
OBJECTIVE: Telomerase activity is detected in most malignant tumors and is also known to have a close relationship with cell proliferation. Cholesteatoma shows cellular hyperproliferation. We studied telomerase activity in cholesteatoma and its relationship with cellular proliferation and clinical findings.
MATERIAL AND METHODS: Cholesteatoma tissue was obtained from 40 patients during middle ear surgery. Telomerase activity was measured using a telomeric repeat amplification protocol method. As a cellular proliferation index, expression of Ki-67 was measured by means of immunohistochemical staining. Posterior auricular skin was used as a control. Telomerase activity was compared with Ki-67 expression. Clinical features such as hearing loss, the extension of cholesteatoma, the degree of bone destruction and the cause of cholesteatomas were compared with telomerase activity and the cellular proliferation index.
RESULTS: Telomerase activity was positive in 21/40 cholesteatomas (52.5%), but absent in the control group. The average Ki-67 labeling index in the cholesteatoma group was 32.84+/-10.13, higher than that in the control group (21.83+/-7.76) (p<0.05). The average Ki-67 labeling indices of the 21 telomerase activity-positive and 19 telomerase activity-negative cholesteatomas were 37.76+/-8.53 and 27.39+/-9.06, respectively. The Ki-67 labeling index was significantly higher in telomerase-positive cholesteatomas (p<0.05). The clinical features did not show a relationship with either telomerase activity or the cellular proliferation index.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012031     DOI: 10.1080/00016480410024479

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

1.  The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.

Authors:  Wei Liu; Hongmiao Ren; Jihao Ren; Tuanfang Yin; Bing Hu; Shumin Xie; Yinghuan Dai; Weijing Wu; Zian Xiao; Xinming Yang; Dinghua Xie
Journal:  Mediators Inflamm       Date:  2013-11-07       Impact factor: 4.711

2.  Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.

Authors:  Mahmood A Hamed; Seiichi Nakata; Kazuya Shiogama; Kenji Suzuki; Ramadan H Sayed; Yoichi Nishimura; Noboru Iwata; Kouhei Sakurai; Badawy S Badawy; Ken-Ichi Inada; Hayato Tsuge; Yutaka Tsutsumi
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-12       Impact factor: 3.372

3.  Neoplasia in Cri du Chat Syndrome from Italian and German Databases.

Authors:  Andrea Guala; Marianna Spunton; Silvia Kalantari; Ingo Kennerknecht; Cesare Danesino
Journal:  Case Rep Genet       Date:  2017-04-24

Review 4.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

5.  Differential Expression of Ki-67 and P27 in Cholesteatoma Compared to Skin Tissue Predicts the Prognosis of Adult Acquired Cholesteatoma.

Authors:  Serkan Türkili; Kemal Görür; Onur İsmi; Ebru Serinsöz Linke; Yusuf Vayısoğlu; Cengiz Özcan
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.